E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/21/2006 in the Prospect News Biotech Daily.

Stryker keeps market perform rating from JMP

Stryker Corp. was maintained at market perform by JMP Securities analyst Robert C. Faulkner on questions about OP-1 and whether the trial hit its endpoint. JMP did not change its 2006 earnings-per-share estimate but did adjust downward its 2007 earnings-per-share estimate to $2.42, from $2.51. Shares of the Kalamazoo, Mich., medical instrument company were up $1.58, or 3.59%, at $45.58 on volume of 5,263,100 shares versus the three-month running average of 1,641,270 shares. (NYSE: SYK)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.